Growth Metrics

Organon (OGN) Cash from Financing Activities (2020 - 2025)

Organon has reported Cash from Financing Activities over the past 6 years, most recently at -$187.0 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$187.0 million for Q4 2025, down 128.05% from a year ago — trailing twelve months through Dec 2025 was -$561.0 million (down 52.45% YoY), and the annual figure for FY2025 was -$561.0 million, down 52.45%.
  • Cash from Financing Activities for Q4 2025 was -$187.0 million at Organon, down from -$76.0 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for OGN hit a ceiling of $345.0 million in Q2 2021 and a floor of -$1.1 billion in Q1 2021.
  • Median Cash from Financing Activities over the past 5 years was -$82.0 million (2022), compared with a mean of -$145.4 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 150.29% in 2021 and later tumbled 327.78% in 2022.
  • Organon's Cash from Financing Activities stood at -$187.0 million in 2021, then soared by 56.15% to -$82.0 million in 2022, then grew by 6.1% to -$77.0 million in 2023, then decreased by 6.49% to -$82.0 million in 2024, then plummeted by 128.05% to -$187.0 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$187.0 million (Q4 2025), -$76.0 million (Q3 2025), and -$223.0 million (Q2 2025) per Business Quant data.